Sensory neuropeptides are potent chemoattractants for human basophils in vitro

Regulatory Peptides

Volumn 160, Issue 1-3, 2010, Pages 42-48

  Cima, Katharina ^a   Vogelsinger, Helene ^a   Kähler, Christian M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Basophil; Chemotaxis; Neurogenic inflammation; Secretoneurin; Substance P

Indexed keywords

CHEMOATTRACTANT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROPEPTIDE; PEPTIDE ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE; SECRETONEURIN; SUBSTANCE P;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BASOPHIL; CELL ISOLATION; CELL MIGRATION; CELL SELECTION; CONTROLLED STUDY; DRUG TARGETING; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BASOPHILS; CELL MOVEMENT; CELLS, CULTURED; CHEMOTACTIC FACTORS; HUMANS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; SECRETOGRANIN II; SIGNAL TRANSDUCTION; SUBSTANCE P;

EID: 74749083431     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.12.013     Document Type: Article

References (37)

1. Payan D.G. Neuropeptides and inflammation: the role of substance P. Annu Rev Med 40 (1989) 341-352
2. Barnes P.J. Neurogenic inflammation in the airways. Respir Physiol 125 1-2 (2001) 145-154
3. Korsgren M., Erjefalt J.S., Hinterholzl J., Fischer-Colbrie R., Emanuelsson C.A., Andersson M., et al. Neural expression and increased lavage fluid levels of secretoneurin in seasonal allergic rhinitis. Am J Respir Crit Care Med 167 11 (2003) 1504-1508
4. Joos G.F., Germonpre P.R., and Pauwels R.A. Neural mechanisms in asthma. Clin Exp Allergy 30 Suppl 1 (2000) 60-65
5. Wedemeyer J., Tsai M., and Galli S.J. Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 12 6 (2000) 624-631
6. Gibbs B.F., Haas H., Falcone F.H., Albrecht C., Vollrath I.B., Noll T., et al. Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur J Immunol 26 10 (1996) 2493-2498
7. Mukai K., Matsuoka K., Taya C., Suzuki H., Yokozeki H., Nishioka K., et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 23 2 (2005) 191-202
8. Fischer-Colbrie R., Laslop A., and Kirchmair R. Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. Prog Neurobiol 46 1 (1995) 49-70
9. De Swert K.O., and Joos G.F. Extending the understanding of sensory neuropeptides. Eur J Pharmacol 533 1-3 (2006) 171-181
10. Reinisch N., Kirchmair R., Kahler C.M., Hogue-Angeletti R., Fischer-Colbrie R., Winkler H., et al. Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett 334 1 (1993) 41-44
11. Dunzendorfer S., Kaser A., Meierhofer C., Tilg H., and Wiedermann C.J. Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol 166 4 (2001) 2167-2172
12. Dunzendorfer S., Schratzberger P., Reinisch N., Kahler C.M., and Wiedermann C.J. Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils. Blood 91 5 (1998) 1527-1532
13. Feistritzer C., Mosheimer B.A., Colleselli D., Wiedermann C.J., and Kahler C.M. Effects of the neuropeptide secretoneurin on natural killer cell migration and cytokine release. Regul Pept 126 3 (2005) 195-201
14. Kahler C.M., Kaufmann G., Kahler S.T., and Wiedermann C.J. The neuropeptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro. Regul Pept 110 1 (2002) 65-73
15. Kahler C.M., Bellmann R., Reinisch N., Schratzberger P., Gruber B., and Wiedermann C.J. Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin. Eur J Pharmacol 304 1-3 (1996) 135-139
16. Kahler C.M., Schratzberger P., and Wiedermann C.J. Response of vascular smooth muscle cells to the neuropeptide secretoneurin. A functional role for migration and proliferation in vitro. Arterioscler Thromb Vasc Biol 17 10 (1997) 2029-2035
17. O'Connor T.M., O'Connell J., O'Brien D.I., Goode T., Bredin C.P., and Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 201 2 (2004) 167-180
18. DeRose V., Robbins R.A., Snider R.M., Spurzem J.R., Thiele G.M., Rennard S.I., et al. Substance P increases neutrophil adhesion to bronchial epithelial cells. J Immunol 152 3 (1994) 1339-1346
19. Schratzberger P., Reinisch N., Prodinger W.M., Kahler C.M., Sitte B.A., Bellmann R., et al. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol 158 8 (1997) 3895-3901
20. Numao T., and Agrawal D.K. Neuropeptides modulate human eosinophil chemotaxis. J Immunol 149 10 (1992) 3309-3315
21. Feistritzer C., Clausen J., Sturn D.H., Djanani A., Gunsilius E., Wiedermann C.J., et al. Natural killer cell functions mediated by the neuropeptide substance P. Regul Pept 116 1-3 (2003) 119-126
22. Payan D.G., and Goetzl E.J. Substance P receptor-dependent responses of leukocytes in pulmonary inflammation. Annu Rev Respir Dis 136 6 Pt 2 (1987) S39-S43
23. Bardelli C., Gunella G., Varsaldi F., Balbo P., Del Boca E., Bernardone I.S., et al. Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway. Br J Pharmacol 145 3 (2005) 385-396
24. Dunzendorfer S., Feistritzer C., Enrich B., and Wiedermann C.J. Neuropeptide-induced inhibition of IL-16 release from eosinophils. Neuroimmunomodulation 10 4 (2002) 217-223
25. Korsgren M., Fischer-Colbrie R., Andersson M., Coman W.B., Mackay-Sim A., Persson C.G., et al. Secretoneurin is released into human airways by topical histamine but not capsaicin. Allergy 60 4 (2005) 459-463
26. Chalastras T., Nicolopoulou-Stamati P., Patsouris E., Eleftheriadou A., Kandiloros D., Yiotakis I., et al. Expression of substance P, vasoactive intestinal peptide and heat shock protein 70 in nasal mucosal smears of patients with allergic rhinitis: investigation using a liquid-based method. J Laryngol Otol 122 7 (2008) 700-706
27. Kirchmair R., Marksteiner J., Troger J., Mahata S.K., Mahata M., Donnerer J., et al. Human and rat primary C-fibre afferents store and release secretoneurin, a novel neuropeptide. Eur J NeuroSci 6 5 (1994) 861-868
28. Gibbs B.F., Rathling A., Zillikens D., Huber M., and Haas H. Initial Fc epsilon RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation. J Allergy Clin Immunol 118 5 (2006) 1060-1067
29. Wiedermann C.J., Wiedermann F.J., Apperl A., Kieselbach G., Konwalinka G., and Braunsteiner H. In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P. Naunyn Schmiedebergs Arch Pharmacol 340 2 (1989) 185-190
30. Cialdai C., Tramontana M., Patacchini R., Lecci A., Catalani C., Catalioto R.M., et al. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist. Eur J Pharmacol 549 1-3 (2006) 140-148
31. Barnes P.J. Neurogenic inflammation and asthma. J Asthma 29 3 (1992) 165-180
32. Bai T.R., Zhou D., Weir T., Walker B., Hegele R., Hayashi S., et al. Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol 269 3 Pt 1 (1995) L309-L317
33. Schneitler C., Kahler C., Wiedermann C.J., Hogue-Angeletti R., and Fischer-Colbrie R. Specific binding of a 125I-secretoneurin analogue to a human monocytic cell line. J Neuroimmunol 86 1 (1998) 87-91
34. Thelen M., Uguccioni M., and Bosiger J. PI 3-kinase-dependent and independent chemotaxis of human neutrophil leukocytes. Biochem Biophys Res Commun 217 3 (1995) 1255-1262
35. Sha Q., Poulsen L.K., Gerwien J., Dum N., and Skov P.S. Signaling transduction pathways involved in basophil adhesion and histamine release. Chin Med J (Engl) 119 2 (2006) 122-130
36. Weston M.C., Anderson N., and Peachell P.T. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function. Br J Pharmacol 121 2 (1997) 287-295
37. Hatzelmann A., Tenor H., and Schudt C. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Br J Pharmacol 114 4 (1995) 821-831